A pharmacologic agent that could facilitate the induction of a posterior vitreous detachment would allow for the treatment of symptomatic VMA in a large pool of patients that do not have a ...
The pathogenesis of a rhegmatogenous retinal detachment involves vitreous syneresis followed by posterior vitreous detachment, leading to vitreoretinal traction and formation of retinal break(s).